Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Diabetes and Vascular Disease Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chu, J. W
Right arrow Articles by Tsao, P. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, J. W
Right arrow Articles by Tsao, P. S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects

James W Chu

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Fahim Abbasi

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Cynthia Lamendola

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Tracey McLaughlin

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Gerald M Reaven

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Philip S Tsao

Department of Medicine, Stanford University School of Medicine, Stanford, California, 94305, US

Thiazolidinedione (TZD) compounds enhance insulin sensitivity and attenuate inflammation. The effect of the TZD compound, rosiglitazone (RSG) on both actions was evaluated in two groups of insulin-resistant subjects with minimal elevations of fasting plasma glucose (PG) concentration: group A (n=15, PG < 7.0 mmol/L) and group B (n=14, PG 7.0–8.3 mmol/L). Insulin action, quantified by the insulin suppression test, improved after three months of treatment in both groups, and concentrations of C-reactive protein, plasminogen activator inhibitor-1 and E-selectin all fell. Significant decreases in L-selectin and P-selectin were confined to group B, and concentrations of interleukin-6, intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1 did not fall in either group.

Significant relationships were not discerned between enhanced insulin sensitivity and related variables and decreases in inflammatory/vascular markers, suggesting that RSG-induced changes in the latter variables in insulin-resistant individuals might be at least partly independent of the effects of the drug on insulin action.

Key Words: insulin resistance • inflammatory markers • thiazolidinedione compounds • insulin sensitivity • rosiglitazone

Diabetes and Vascular Disease Research, Vol. 2, No. 1, 37-41 (2005)
DOI: 10.3132/dvdr.2005.004


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
R. T. Zamanian, G. Hansmann, S. Snook, D. Lilienfeld, K. M. Rappaport, G. M. Reaven, M. Rabinovitch, and R. L. Doyle
Insulin resistance in pulmonary arterial hypertension
Eur. Respir. J., February 1, 2009; 33(2): 318 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven
The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5002 - 5007.
[Abstract] [Full Text] [PDF]